{"id":1755,"date":"2023-04-26T01:30:02","date_gmt":"2023-04-25T16:30:02","guid":{"rendered":"https:\/\/prismbiolab.com\/?p=1755"},"modified":"2023-04-26T18:26:51","modified_gmt":"2023-04-26T09:26:51","slug":"approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery","status":"publish","type":"post","link":"https:\/\/prismbiolab.com\/ja\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/","title":{"rendered":"Approved Peptide-based Therapeutics and Recent Relevance with Drug Discovery"},"content":{"rendered":"<div id=\"pl-1755\"  class=\"panel-layout\" ><div id=\"pg-1755-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-1755-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-1755-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p>This review<sup>1)<\/sup> summarizes the recent status of peptide-based therapeutics research in the discovery stage and peptide related technologies in a simple fashion. It helps scientist in a variety of levels to achieve better understanding of peptide drug discovery issues as well.<\/p>\n<p>Peptides are among the classical and ubiquitous chemical types in the small-molecule world. Distinct and attractive nature of peptides is highlighted by the moderate to high potency, target specificity, less toxicity and storability.<br \/>\nSynthetic utility is also the fascinating: diverse technologies like automatic synthesis, flow synthesis and DNA-encoded libraries are readily available these days.<br \/>\nAs one of the leading companies of peptidomimetics, recent updates in the peptide field is of great interest in PRISM Biolab.<\/p>\n<p>You would think peptides are fascinating by looking at the coverage of disease fields of these approved drugs.<br \/>\nThe top 5 are Infection (17), anticancer (16), diagnostic agents (15), cardiovascular diseases (11) and diabetes (9). Obviously, peptide-based therapeutics are becoming remedies in the intensively investigated and challenged disease areas. According to this literature1), 47 clinical trials were on-going at the stage of Jul., 2022. <\/p>\n<p>However, peptide drugs cover only 6% of the FDA-approved therapeutics (approved from Jan., 1940~Jul., 2022)<sup>1)<\/sup>. As mentioned in other articles, peptides have limitations in drug development. The crucial issue for delivering widely available and preferred therapeutics is that poor metabolic stability and membrane permeability hampers the oral administration of natural peptide-based drugs.<br \/>\nIn order to overcome the limitation and control the chemical and pharmacological nature of peptide therapeutics, numerous technologies and approaches have been developed so far.<br \/>\nReplacement of labile amide bonds<sup>2)<\/sup>, backbone modifications<sup>3)<\/sup>, N-alkylation<sup>4)<\/sup>, cyclic peptide synthesis<sup>5)<\/sup> are a kind of \u201cestablished\u201d synthetic methodologies. However, the trial-and-error-based synthesis and profile tests is a huge barrier for concise and rapid lead optimization.<br \/>\nHow attractive it would be to have a peptidomimetic molecule not only with high potency and selectivity but also with metabolic stability and membrane permeability!<\/p>\n<p>Advance of peptide drugs will provide a new opportunity for peptide mimetic small molecules, including our PepMetics<sup>\u00ae<\/sup><sup>. Once the mechanism is confirmed with peptides, PepMetics<\/sup><sup>\u00ae<\/sup><sup>, which mimic the sequence of key interactions, have a potential to act in the same as the parent.<br \/>\nLimitations and issues will be surmounted or circumvented by sophisticated technologies. Reading this review would be a \u201ccatalyst\u201d to open up your mind.<br \/>\nWe are always welcome to have a scientific discussion and appreciate your collaboration to deliver novel drugs to patients with high useability.<\/p>\n<p>1) <a href=\"https:\/\/doi.org\/10.1016\/j.drudis.2022.103464\" rel=\"noopener\" target=\"_blank\">https:\/\/doi.org\/10.1016\/j.drudis.2022.103464<\/a><br \/>\n2) <a href=\"https:\/\/doi.org\/10.1039\/C3CS60384A\" rel=\"noopener\" target=\"_blank\">https:\/\/doi.org\/10.1039\/C3CS60384A<\/a><br \/>\n3) <a href=\"https:\/\/doi.org\/10.1039\/D1QO00892G\" rel=\"noopener\" target=\"_blank\">https:\/\/doi.org\/10.1039\/D1QO00892G<\/a><br \/>\n4) <a href=\"https:\/\/doi.org\/10.1021\/ar8000603\" rel=\"noopener\" target=\"_blank\">https:\/\/doi.org\/10.1021\/ar8000603<\/a><br \/>\n5) <a href=\"https:\/\/doi.org\/10.1021\/acs.chemrev.8b00657\" rel=\"noopener\" target=\"_blank\">https:\/\/doi.org\/10.1021\/acs.chemrev.8b00657<\/a><br \/>\n<\/sup><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>This review<sup>1)<\/sup> summarizes the recent status of peptide-based therapeutics research in the discovery stage and peptide related technologies in a simple fashion. It helps scientist in a variety of levels to achieve better understanding of peptide drug discovery issues as well.<br \/>\nPeptides are among the classical and ubiquitous chemical types in the small-molecule world. Distinct and attractive nature of peptides&#8230;<\/p>","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-1755","post","type-post","status-publish","format-standard","hentry","category-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Approved Peptide-based Therapeutics and Recent Relevance with Drug Discovery - PRISM BioLab<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prismbiolab.com\/ja\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Approved Peptide-based Therapeutics and Recent Relevance with Drug Discovery - PRISM BioLab\" \/>\n<meta property=\"og:description\" content=\"This review1) summarizes the recent status of peptide-based therapeutics research in the discovery stage and peptide related technologies in a simple fashion. It helps scientist in a variety of levels to achieve better understanding of peptide drug discovery issues as well. Peptides are among the classical and ubiquitous chemical types in the small-molecule world. Distinct and attractive nature of peptides...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prismbiolab.com\/ja\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/\" \/>\n<meta property=\"og:site_name\" content=\"PRISM BioLab\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-25T16:30:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-26T09:26:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prismbiolab.com\/wp-content\/uploads\/2023\/03\/career-collage-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1122\" \/>\n\t<meta property=\"og:image:height\" content=\"1097\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"vera\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/prismbiolab.com\/wp-content\/uploads\/2023\/03\/career-collage-1.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"vera\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\\\/\"},\"author\":{\"name\":\"vera\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#\\\/schema\\\/person\\\/c39849cfa45a5eee95d62d3998e14ac9\"},\"headline\":\"Approved Peptide-based Therapeutics and Recent Relevance with Drug Discovery\",\"datePublished\":\"2023-04-25T16:30:02+00:00\",\"dateModified\":\"2023-04-26T09:26:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\\\/\"},\"wordCount\":431,\"publisher\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#organization\"},\"articleSection\":[\"Blog\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\\\/\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\\\/\",\"name\":\"Approved Peptide-based Therapeutics and Recent Relevance with Drug Discovery - PRISM BioLab\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#website\"},\"datePublished\":\"2023-04-25T16:30:02+00:00\",\"dateModified\":\"2023-04-26T09:26:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/prismbiolab.com\\\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/prismbiolab.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Approved Peptide-based Therapeutics and Recent Relevance with Drug Discovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#website\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/\",\"name\":\"PRISM BioLab\",\"description\":\"PRISM BioLab MIMICS natural  peptides leading to cures of the  greatest health challenges\",\"publisher\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/prismbiolab.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#organization\",\"name\":\"PRISM BioLab\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/prismbiolab.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/prism_logo_b.jpg\",\"contentUrl\":\"https:\\\/\\\/prismbiolab.com\\\/wp-content\\\/uploads\\\/2021\\\/09\\\/prism_logo_b.jpg\",\"width\":300,\"height\":367,\"caption\":\"PRISM BioLab\"},\"image\":{\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/prismbiolab.com\\\/#\\\/schema\\\/person\\\/c39849cfa45a5eee95d62d3998e14ac9\",\"name\":\"vera\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e9f830f27345ae572541f7e2ee9538c9139cea2ecec346fce05674c00451c0c9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e9f830f27345ae572541f7e2ee9538c9139cea2ecec346fce05674c00451c0c9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e9f830f27345ae572541f7e2ee9538c9139cea2ecec346fce05674c00451c0c9?s=96&d=mm&r=g\",\"caption\":\"vera\"},\"url\":\"https:\\\/\\\/prismbiolab.com\\\/ja\\\/author\\\/labprzm_\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Approved Peptide-based Therapeutics and Recent Relevance with Drug Discovery - PRISM BioLab","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prismbiolab.com\/ja\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/","og_locale":"ja_JP","og_type":"article","og_title":"Approved Peptide-based Therapeutics and Recent Relevance with Drug Discovery - PRISM BioLab","og_description":"This review1) summarizes the recent status of peptide-based therapeutics research in the discovery stage and peptide related technologies in a simple fashion. It helps scientist in a variety of levels to achieve better understanding of peptide drug discovery issues as well. Peptides are among the classical and ubiquitous chemical types in the small-molecule world. Distinct and attractive nature of peptides...","og_url":"https:\/\/prismbiolab.com\/ja\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/","og_site_name":"PRISM BioLab","article_published_time":"2023-04-25T16:30:02+00:00","article_modified_time":"2023-04-26T09:26:51+00:00","og_image":[{"width":1122,"height":1097,"url":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2023\/03\/career-collage-1.jpg","type":"image\/jpeg"}],"author":"vera","twitter_card":"summary_large_image","twitter_image":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2023\/03\/career-collage-1.jpg","twitter_misc":{"\u57f7\u7b46\u8005":"vera","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prismbiolab.com\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/#article","isPartOf":{"@id":"https:\/\/prismbiolab.com\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/"},"author":{"name":"vera","@id":"https:\/\/prismbiolab.com\/#\/schema\/person\/c39849cfa45a5eee95d62d3998e14ac9"},"headline":"Approved Peptide-based Therapeutics and Recent Relevance with Drug Discovery","datePublished":"2023-04-25T16:30:02+00:00","dateModified":"2023-04-26T09:26:51+00:00","mainEntityOfPage":{"@id":"https:\/\/prismbiolab.com\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/"},"wordCount":431,"publisher":{"@id":"https:\/\/prismbiolab.com\/#organization"},"articleSection":["Blog"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/prismbiolab.com\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/","url":"https:\/\/prismbiolab.com\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/","name":"Approved Peptide-based Therapeutics and Recent Relevance with Drug Discovery - PRISM BioLab","isPartOf":{"@id":"https:\/\/prismbiolab.com\/#website"},"datePublished":"2023-04-25T16:30:02+00:00","dateModified":"2023-04-26T09:26:51+00:00","breadcrumb":{"@id":"https:\/\/prismbiolab.com\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prismbiolab.com\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/prismbiolab.com\/approved-peptide-based-therapeutics-and-recent-relevance-with-drug-discovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/prismbiolab.com\/"},{"@type":"ListItem","position":2,"name":"Approved Peptide-based Therapeutics and Recent Relevance with Drug Discovery"}]},{"@type":"WebSite","@id":"https:\/\/prismbiolab.com\/#website","url":"https:\/\/prismbiolab.com\/","name":"PRISM BioLab","description":"PRISM BioLab MIMICS natural  peptides leading to cures of the  greatest health challenges","publisher":{"@id":"https:\/\/prismbiolab.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prismbiolab.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/prismbiolab.com\/#organization","name":"PRISM BioLab","url":"https:\/\/prismbiolab.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/prismbiolab.com\/#\/schema\/logo\/image\/","url":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2021\/09\/prism_logo_b.jpg","contentUrl":"https:\/\/prismbiolab.com\/wp-content\/uploads\/2021\/09\/prism_logo_b.jpg","width":300,"height":367,"caption":"PRISM BioLab"},"image":{"@id":"https:\/\/prismbiolab.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/prismbiolab.com\/#\/schema\/person\/c39849cfa45a5eee95d62d3998e14ac9","name":"vera","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/secure.gravatar.com\/avatar\/e9f830f27345ae572541f7e2ee9538c9139cea2ecec346fce05674c00451c0c9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9f830f27345ae572541f7e2ee9538c9139cea2ecec346fce05674c00451c0c9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9f830f27345ae572541f7e2ee9538c9139cea2ecec346fce05674c00451c0c9?s=96&d=mm&r=g","caption":"vera"},"url":"https:\/\/prismbiolab.com\/ja\/author\/labprzm_\/"}]}},"_links":{"self":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/posts\/1755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/comments?post=1755"}],"version-history":[{"count":2,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/posts\/1755\/revisions"}],"predecessor-version":[{"id":1757,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/posts\/1755\/revisions\/1757"}],"wp:attachment":[{"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/media?parent=1755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/categories?post=1755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prismbiolab.com\/ja\/wp-json\/wp\/v2\/tags?post=1755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}